Direct and indirect health economic impact of hypoglycaemia in a global population of patients with insulin-treated diabetes

Diabetes Research and Clinical Practice

Volumn 138, Issue , 2018, Pages 35-43

  Aronson, Ronnie ^a   Galstyan, Gagik ^b   Goldfracht, Margalit ^c   Al Sifri, Saud ^d   Elliott, Lisa ^e   Khunti, Kamlesh ^f  

^a LMC DIABETES AND ENDOCRINOLOGY   (Canada)

^b ENDOCRINOLOGY RESEARCH CENTRE   (Russian Federation)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d AL HADA ARMED FORCES HOSPITAL   (Saudi Arabia)

^e NOVO NORDISK A S   (Denmark)

^f UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Diabetes; Hypoglycaemia; Insulin; Medical economics; Type 1 diabetes; Type 2 diabetes

Indexed keywords

INSULIN; ANTIDIABETIC AGENT;

ABSENTEEISM; ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CANADA; EUROPE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RUSSIAN FEDERATION; SOUTH AND CENTRAL AMERICA; SOUTHEAST ASIA; CLINICAL TRIAL; ECONOMICS; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY;

ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 85041379837     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2018.01.007     Document Type: Article

References (25)

1. Munro, N., Barnett, A.H., Incidence, worry and discussion about dosing irregularities and self-treated hypoglycaemia amongst HCPs and patients with type 2 diabetes: results from the UK cohort of the Global Attitudes of Patient and Physicians (GAPP2) survey. Int J Clin Pract 68 (2014), 692–699.
2. Edridge, C.L., Dunkley, A.J., Bodicoat, D.H., Rose, T.C., Gray, L.J., Davies, M.J., et al. Prevalence and incidence of hypoglycaemia in 532,542 people with type 2 diabetes on oral therapies and insulin: A systematic review and meta-analysis of population based studies. PLoS ONE, 10, 2015, e0126427.
3. Brod, M., Wolden, M., Christensen, T., Bushnell, D.M., Understanding the economic burden of nonsevere nocturnal hypoglycemic events: impact on work productivity, disease management, and resource utilization. Value Health: J Int Soc Pharmacoecon Outcomes Res 16 (2013), 1140–1149.
4. Geelhoed-Duijvestijn, P.H., Pedersen-Bjergaard, U., Weitgasser, R., Lahtela, J., Jensen, M.M., Ostenson, C.G., Effects of patient-reported non-severe hypoglycemia on healthcare resource use, work-time loss, and wellbeing in insulin-treated patients with diabetes in seven European countries. J Med Econo 16 (2013), 1453–1461.
5. Leiter, L.A., Boras, D., Woo, V.C., Dosing irregularities and self-treated hypoglycemia in type 2 diabetes: results from the Canadian cohort of an international survey of patients and healthcare professionals. Can J Diabetes 38 (2014), 38–44.
6. Ostenson, C.G., Geelhoed-Duijvestijn, P., Lahtela, J., Weitgasser, R., Markert Jensen, M., Pedersen-Bjergaard, U., Self-reported non-severe hypoglycaemic events in Europe. Diabetic Med: J Brit Diabetic Assoc 31 (2014), 92–101.
7. Elliott, L., Fidler, C., Ditchfield, A., Stissing, T., Hypoglycemia event rates: a comparison between real-world data and randomized controlled trial populations in insulin-treated diabetes. Diabetic Therapy: Res, Treat Educ Diabetic Relat Disord 7 (2016), 45–60.
8. Hammer, M., Lammert, M., Mejias, S.M., Kern, W., Frier, B.M., Costs of managing severe hypoglycaemia in three European countries. J Med Econ 12 (2009), 281–290.
9. Hex, N., Bartlett, C., Wright, D., Taylor, M., Varley, D., Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabetic Med: J Brit Diabetic Assoc 29 (2012), 855–862.
10. Leese, G.P., Wang, J., Broomhall, J., Kelly, P., Marsden, A., Morrison, W., et al. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care 26 (2003), 1176–1180.
11. McEwan, P., Larsen Thorsted, B., Wolden, M., Jacobsen, J., Evans, M., Healthcare resource implications of hypoglycemia-related hospital admissions and inpatient hypoglycemia: retrospective record-linked cohort studies in England. BMJ Open Diabetes Res Care, 3, 2015, e000057.
12. Brod, M., Christensen, T., Thomsen, T.L., Bushnell, D.M., The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value Health: J Int Soc Pharmacoecon Outcomes Res 14 (2011), 665–671.
13. Khunti, K., Alsifri, S., Aronson, R., Cigrovski Berkovic, M., Enters-Weijnen, C., Forsen, T., et al. Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study. Diabetes Obes Metab 18 (2016), 907–915.
14. Workgroup on Hypoglycemia, American Diabetes Association, Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 28 (2005), 1245–1249.
15. da Rocha Fernandes, J., Ogurtsova, K., Linnenkamp, U., Guariguata, L., Seuring, T., Zhang, P., et al. IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes. Diabetes Res Clin Pract 117 (2016), 48–54.
16. Zhang, P., Zhang, X., Brown, J., Vistisen, D., Sicree, R., Shaw, J., et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 87 (2010), 293–301.
17. Seuring, T., Archangelidi, O., Suhrcke, M., The economic costs of type 2 diabetes: a global systematic review. PharmacoEcon 33 (2015), 811–831.
18. American Diabetes Association, Economic costs of diabetes in the U.S. in 2012. Diabetes Care 36 (2013), 1033–1046.
19. Witvliet, M.I., Kunst, A.E., Stronks, K., Arah, O.A., Variations between world regions in individual health: a multilevel analysis of the role of socio-economic factors. Eur J Pub Health 22 (2012), 284–289.
20. Rampal, S., Rampal, L., Rahmat, R., Azhar, Md.Z., Yee Guan, Y., Mohamed, M., et al. Variation in the prevalence, awareness, and control of diabetes in a multiethnic population: a nationwide population study in Malaysia. Asia Pacific J Public Health 22 (2009), 194–202.
21. OECD Indicators. Health at a Glance 2011. OECD Indicators. Available at http://doi.org/10.1787/888932525590; 2011.
22. Heller, S.R., Frier, B.M., Herslov, M.L., Gundgaard, J., Gough, S.C., Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources. Diabetic Med: J Brit Diabetic Assoc 33 (2016), 471–477.
23. Brod, M., Rana, A., Barnett, A.H., Impact of self-treated hypoglycaemia in type 2 diabetes: a multinational survey in patients and physicians. Curr Med Res Opin 28 (2012), 1947–1958.
24. Brod, M., Wolden, M., Christensen, T., Bushnell, D.M., A nine country study of the burden of non-severe nocturnal hypoglycaemic events on diabetes management and daily function. Diabetes Obes Metab 15 (2013), 546–557.
25. Khunti, K., Fisher, H., Paul, S., Iqbal, M., Davies, M.J., Siriwardena, A.N., Severe hypoglycaemia requiring emergency medical assistance by ambulance services in the East Midlands: a retrospective study. Primary Care Diabetes 7 (2013), 159–165.